Skip to content

I-gel Plus Supraglottic Airway Device for Surgical Procedures in Prone Position

The I-gel Plus Supraglottic Airway Device for Elective Surgical Procedures in Prone Position

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06602817
Enrollment
28
Registered
2024-09-19
Start date
2024-10-01
Completion date
2025-02-04
Last updated
2025-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Management, General Anesthesia, Supraglottic Airway

Keywords

Prone position, Surgery, Airway management

Brief summary

I-gel Plus is a novel supraglottic airway device that has been evaluated in various studies with high success and low complication rates. Feasibility of supraglottic airway devices (SGA) in patients undergoing surgery in prone position has been demonstrated in some pilot studies and case series; however, the evidence is still limited. It is currently uncertain, if the i-gel Plus facilitates appropriate ventilation in individuals undergoing elective surgery in prone position. The primary aim of this single-center non-inferior study is to assess the leak fraction of the i-gel Plus in patients undergoing surgery in prone position and to compare it with data from an existing prospective control cohort in patients undergoing surgery in supine position. Secondary aims are to investigate the oropharyngeal seal pressure and other secondary outcome parameters and to compare them with the control cohort.

Interventions

OTHERExposure: prone position

Exposure: surgery in prone position

OTHERExposure: Supine position

Exposure: Surgery in supine position

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduling for elective surgery in prone position * Planned airway management using a SGA * Adult patients (age 18-89 years) * ASA physical status 1-3

Exclusion criteria

* Pregnant or breastfeeding women * Non-fasted patients * Increased risk of aspiration or other contraindications for supraglottic mask ventilation * Shared airway or intracavity open surgery * Body mass index (BMI) >35 kg/m2 * Inability to understand or sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Leak fraction3 hoursVentilation parameter - Leakage volume per tidal volume

Secondary

MeasureTime frameDescription
Leakage volume (ml)3 hoursVentilation parameter - as displayed on the ventilator
Tidal volume (ml)3 hoursVentilation parameter - as displayed on the ventilator
Inspiratory peak pressure (cm H2O)3 hoursVentilation parameter - as displayed on the ventilator
Positive endexpiratory pressure (PEEP) (cm H2O)3 hoursVentilation parameter - as displayed on the ventilator
Respiratory rate (1/min)3 hoursVentilation parameter - as displayed on the ventilator
Minute ventilation (l/min/kg)3 hoursVentilation parameter -as displayed on the ventilator
Endtidal CO2 [mmHg]3 hoursVentilation parameter - as displayed on the ventilator
Number of insertion attempts3 hoursClinical assessment - SGA insertion attempts
Oropharyngeal seal pressure [cm H2O]3 hoursClinical assessment - leak pressure with audible leak
First-attempt insertion success rate (%)3 hoursClinical assessment - successful placement in only one insertion attempt
Necessity of adjustment maneuvers during the procedure3 hoursClinical assessment
Insertion time (sec)3 hoursClinical assessment
Lowest oxygen saturation (%)3 hoursMeasured by pulse oximetry
Difficulty of insertion3 hoursClinical assessment on a scale between 1-5
Ease of gastric tube insertion3 hoursClinical assessment - rating on a scale from 1-5
Postoperative complications24 hours postoperativelyClinical assessment
Complications at the end of surgery3 hoursClinical assessment
Insertion success rate (%)3 hoursClinical assessment

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026